@BactLAB(TM), Bacterial Colony-counting Service, Now Available Globally

Food and Healthcare Press Releases Monday August 5, 2019 12:00
TOKYO--5 Aug--Kyodo JBN- AsiaNet/InfoQuest

Nissui Pharmaceutical Co., Ltd., based in Tokyo, is pleased to announce that @BactLAB(TM), an application that uses Amazon Web Service (AWS) Cloud and artificial intelligence (AI) technologies to enable quick and easy counting of bacterial colonies, is now available to overseas users of CompactDry(TM). The launch of this application is part of the company's strategy of active investment in areas of new growth for the purpose of contributing to the development of overseas markets and quality control processes in relation to food hygiene.

(Logo1: https://kyodonewsprwire.jp/prwfile/release/M105074/201907319276/_prw_PI1fl_1Mft9204.jpg)
(Logo2: https://kyodonewsprwire.jp/img/201907319276-O2-u1982f9w)

Since August 2018, a limited number of Nissui Pharmaceutical's overseas customers have been testing and using @BactLAB(TM), a colony counter application developed exclusively for CompactDry(TM), an easy-to-use medium for measuring bacteria count and also the company's most important product for overseas customers. During this phase, it made several improvements to the application, such as faster counting of colonies, collecting and utilizing AI learning data, new convenience features and additional functions, all of which are now included in the released service.

@BactLAB(TM) official website:
https://www.nissui-pharm.co.jp/english/products/global/bactlab/
Application available at: Google Play / Apple Store / Amazon Appstore / Online Service
(Images1: https://kyodonewsprwire.jp/img/201907319276-O3-TipIpw4F)
@BactLAB(TM) Service Overview
  • Auto count with global cloud access, available on multiple devices (PC / Android / iPhone)
  • Cloud storage function of counted data
  • Exportable reports (in .csv file or .jpg file format)
  • Chat Bot support on the official website
* This service is an application designed exclusively for CompactDry(TM) customers.
* A Wi-Fi environment is recommended when using the smartphone app.
* Depending on the target image, there may be a counting error of up to 8%.
* A colony count result of "0" does not indicate a negative result.
* Nissui Pharmaceutical takes no responsibility for the analysis results provided by this service.
(Images2: https://kyodonewsprwire.jp/prwfile/release/M105074/201907319276/_prw_PI4fl_D1wtD48F.png)
* Google, Google Play, Android and other such marks are trademarks of Google Inc.
* Apple and the Apple logo are trademarks of Apple Inc. registered in the USA and other countries. App Store, AppleCare and iCloud are service marks of Apple Inc. (TM) and (R) Apple Inc. All rights reserved.
* Amazon and Amazon Web Service are trademarks or registered trademarks of Amazon.com, Inc. or its affiliates.
SOURCE: Nissui Pharmaceutical Co., Ltd.
AsiaNet 79935

Latest Press Release

Laboratory Studies Confirm BETADINE(R) Antiseptic Products' Effectiveness Against COVID-19 Virus

Mundipharma today announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE(R) antiseptic products against the novel coronavirus (SARS-CoV-2) which causes COVID-19 disease. Testing has...

How to Sleep Better? Follow These 6 Tips to Get Quality Rest

COVID-19 has changed the lives of people everywhere. Many are working from home and trying to stay connected with colleagues and loved ones through technology. Almost everyone has had their normal routines upset in one way or another, and sleeping...

การประชุมวิชาการโภชนาการแห่งชาติ ครั้งที่ 14 "ชิวิตวิถีใหม่ สู้ภัยโควิด-19 ด้วยอาหารและโภชนาการ"

The 14th Thailand Congress of Nutrition (TCN 2020) "New Normal for Fighting COVID-19 with Food and Nutrition" วันที่ 7-8 ตุลาคม 2563 เนื้อหาที่น่าสนใจ โควิด-19 กับความมั่นคงด้านอาหาร และโภชนาการวิกฤตโควิด-19 ต่อสุขภาพ...

Apollo Proton Cancer Centre Receives Prestigious JCI Accreditation

Apollo Proton Cancer Centre (APCC), the first Proton Therapy Centre in South Asia and the Middle East, announced its accreditation by Joint Commission International (JCI), the recognized global leader in health care accreditation. This makes APCC the...

Affinity discovers potent SARS-CoV-2 antibodies

Melbourne-based Affinity Biosciences Pty Ltd (Affinity), a privately held company focused on antibody discovery for cancer therapeutics, today announces the discovery of potent antibodies with therapeutic potential against COVID-19. In March, Affinity...

Related Topics